Navigation Links
Amgen To Present Data From Four Phase 2 Studies At Upcoming American Heart Association Scientific Sessions 2012
Date:11/2/2012

THOUSAND OAKS, Calif., Nov. 2, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present data from four Phase 2 trials of AMG 145, an investigational fully human monoclonal antibody directed against PCSK9, a protein that reduces the liver's ability to remove low density lipoprotein cholesterol (LDL-C), or "bad" cholesterol from the blood, at the upcoming American Heart Association (AHA) Scientific Sessions 2012.

Selected abstracts of interest that will be presented at the meeting include:

  • Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD): Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
    Late-Breaking Clinical Trials, Monday, Nov. 05, 10:50 a.m. – 11:00 a.m. (Hall G)

  • Goal Achievement after Utilizing an Anti-PCSK9 in Statin Intolerant Subjects (GAUSS): Results from a Randomized, Double-blind, Placebo controlled Study
    Late-Breaking Clinical Trials, Monday, Nov. 05, 11:00 a.m. – 11:10 a.m.  (Hall G)

  • LAPLACE-TIMI 57 Primary Results
    Clinical Science: Special Reports, Tuesday, Nov. 06, 7:45 a.m. – 7:55 a.m.  (Petree Hall D)

  • Efficacy and Safety of a Fully Human Monoclonal Antibody Against PCSK9 as Monotherapy for Hypercholesterolemia: Results from the MENDEL Study, a Global Phase 2 Trial of AMG 145
    Clinical Science: Special Reports, Tuesday, Nov. 06, 7:55 a.m. – 8:05 a.m.  (Petree Hall D)

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics ha
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 A six-hour certification program on ... at the Cannabis World Congress & Business Exposition ... NY .  Taking place on Wednesday, June 17 th ... education at the leading event on the East Coast for ... by Clover Leaf University, the first cannabis university to be ...
(Date:5/29/2015)... DUBLIN , May 28, 2015 ... the addition of Jain PharmaBiotech,s new report ... to their offering. Drug delivery ... to other systems because of the anatomy and ... and nutrients to all organs of the body. ...
(Date:5/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/ltwldz/surgicaloperating ... "Surgical/Operating Microscopes Market by Application & End User ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... to reach $806.6 million by 2020 from $402.2 ... from 2015 to 2020. , ,Major factors fueling ...
Breaking Medicine Technology:Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 3Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2
... penicillin , , , ... June 17 The U.S. Food and Drug Administration today warned consumers ... tests revealed that the fraudulent product does not contain Tamiflu,s active ingredient, oseltamivir, but ... , , ...
... , PITTSBURGH , June 17 Mylan ... Mylan Pharmaceuticals Inc. received final approval from the U.S. Food ... (ANDA) for Hydroxyzine Hydrochloride Tablets 10 mg, 25 mg and ... therefore, therapeutically equivalent to Pliva,s Hydroxyzine Hydrochloride Tablets, a treatment ...
Cached Medicine Technology:FDA Warns About Fraudulent Tamiflu 2FDA Warns About Fraudulent Tamiflu 3Mylan Receives Approval for Hydroxyzine Hydrochloride Tablets 2
(Date:5/30/2015)... You've probably heard that using cotton swabs to ... have you found a better way to remove ear wax? ... what you need. , They developed SUNDENG EAR CLEANER to ... dry skin from the ears. What's more, it is safer ... the market today for children and adults of all ages. ...
(Date:5/30/2015)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 30, ... quick, safe, and simple procedure to lighten or stop ... the risks of hysterectomy. This procedure can reduce or ... or the lining of the uterus (the part that ... energy. , About 10 million women suffer from heavy ...
(Date:5/30/2015)... 2015 On Thursday, May 14, ... Simone and Dr. Evan Alley both of the ... Mesothelioma Experts’ series. The interview was part of ... of excellence. Drs. Simone and Alley were interviewed ... with whom they discussed the mesothelioma program at ...
(Date:5/30/2015)... EHO offers a suite of online ... hospices the ability to manage their drug-spend for the ... model, EHO has been able to compete with the ... and survive among the giants of the industry. Since ... years ago, it has simplified the way hospices can ...
(Date:5/30/2015)... ROTHWELL, Australia (PRWEB) May 30, 2015 At ... the rewards of vibrant health , which she attributes ... personally tested principles of good nutrition with the release of ... ” (published by Xlibris AU). , “Cook for Health and ... using natural, nutritious and mostly organic food . It ...
Breaking Medicine News(10 mins):Health News:Improved Ear Hygiene Tool Invented by InventHelp Clients (KSC-952) 2Health News:Women's Excellence Now Provides NovaSure Treatment 2Health News:Interview with Mesothelioma Experts, Drs. Simone and Alley Now Available on Demand 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 3
... SEATTLE Larry Corey, M.D., president and director of Fred ... the American Academy of Arts and Sciences, one of the ... centers. , "I,m extremely honored to be in the same ... science, medicine and the arts," Corey said. "I,m also very ...
... HealthDay Reporter , TUESDAY, April 17 (HealthDay News) ... through talk therapy and medication. But for some, severe ... turn to brain surgery, and a new study shows ... patients who underwent "stereotactic anterior cingulotomy" at Massachusetts General ...
... (Avastin) to the standard chemotherapy regimen for non-small cell lung ... 2006 did not lead to significantly increase survival rates ... a new study by Dana-Farber Cancer Institute researchers has found. ... Journal of the American Medical Association , a these ...
... Regenstrief Institute investigator Christopher Callahan, M.D., Cornelius and Yvonne ... of Medicine and director of the IU Center for ... Career Achievement and Contribution to Clinical and Translational Science ... D.C., April 18 to 20. Dr. Callahan, who ...
... 16, 2012 Wake Forest Baptist Medical Center researchers seeking a ... size and extent of damaged tissue can be reduced by ... The research, the focus of a three-year, $1.5 million study ... the journal Neurosurgery . The technology, tested in ...
... undergoing chemoradiation therapy (CRT) for head and neck cancer, ... short-term improvement in swallowing function; however, there were no ... and controls at nine or 12 months following treatment, ... Archives of Otolaryngology Head & Neck Surgery ...
Cached Medicine News:Health News:Hutchinson Center president elected to American Academy of Art and Sciences 2Health News:Hutchinson Center president elected to American Academy of Art and Sciences 3Health News:Brain Surgery Might Ease Tough-to-Treat OCD 2Health News:Brain Surgery Might Ease Tough-to-Treat OCD 3Health News:Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients 2Health News:Callahan honored for improving older adults' health in their doctors' offices 2Health News:Mechanical tissue resuscitation technology shows promise 2Health News:Swallowing exercises linked with short-term improvement among patients with head and neck cancer 2
Angled 45 degree shafts with 6 mm tying platform and crisscross serrated tips. Round knurled handle with dull finish. Overall length 4.4 inches....
5 mm tying platform. Round knurled handle with dull finish. Straight shafts. Overall length 3.9 inches....
Hartman Mosquito forceps, straight, 3-1/2", German stainless steel...
Straight 20 mm serrated jaws. Ring handle with ratchet lock and dull finish. Overall length 3.9 inches...
Medicine Products: